29 Results | Everything | Search

Product TypeClear Filters

Analytical Chemistry (1)

Biochemicals (29)

Antivirals (2)

Kinase Inhibitors (29)

Abl Family & Bcr-Abl (3)

Aurora (2)

CaMKs (1)

FGFR Family (8)

HGFR Family (1)

JAK Family (2)

Neurotrophin Receptor/Trk Family (1)

PDGFR Family (15)

RAF (5)

RET (29)

SRC Family (3)

TAM Family (1)

Tec Family (1)

Tie Family (7)

VEGFR Family (13)

Other Receptor Tyrosine Kinases (2)

Other Serine/Threonine Kinases (1)

Xenobiotic Metabolites (2)

Small Molecule Modulators (29)

Research AreaClear Filters

Cancer (23)

Cardiovascular System (1)

Cell Biology (13)

Immunology & Inflammation (7)

Infectious Disease (2)

Neuroscience (2)

Xenobiotic Metabolism (2)

ApplicationClear Filters

Mass Spectrometry (1)

Displaying 1 - 25 of 29 Results

Regorafenib

A multi-kinase inhibitor

CAS No. 755037-03-7

Item No. 18498

Formulation: A crystalline solid

Purity: ≥98%

BAY 73-4506

5 mg

$49

Add

10 mg

$93

Add

25 mg

$130

Add

50 mg

$236

Add

XL184

A VEGFR2 inhibitor

CAS No. 849217-68-1

Item No. 18464

Formulation: A crystalline solid

Purity: ≥98%

BMS-907351
Cabozantinib

1 mg

$49

Add

5 mg

$107

Add

10 mg

$167

Add

50 mg

$587

Add

TG101348

A JAK2 inhibitor

CAS No. 936091-26-8

Item No. 16289

Formulation: A crystalline solid

Purity: ≥98%

Fedratinib
SAR302503

1 mg

$63

Add

5 mg

$129

Add

10 mg

$206

Add

25 mg

$468

Add

AST-487

A multi-kinase inhibitor

CAS No. 630124-46-8

Item No. 19477

Formulation: A crystalline solid

Purity: ≥98%

NVP-AST-487

1 mg

$37

Add

5 mg

$124

Add

10 mg

$229

Add

25 mg

$523

Add

Danusertib

A pan-Aurora kinase and Abl inhibitor

CAS No. 827318-97-8

Item No. 18387

Formulation: A crystalline solid

Purity: ≥95%

PHA-739358

1 mg

$42

Add

5 mg

$147

Add

10 mg

$230

Add

50 mg

$627

Add

ALW-II-41-27

A multi-kinase inhibitor

CAS No. 1186206-79-0

Item No. 25275

Formulation: A crystalline solid

Purity: ≥95%

1 mg

$69

Add

5 mg

$297

Add

10 mg

$525

Add

TG101209

An inhibitor of JAK2, FLT3, RET, and JAK3

CAS No. 936091-14-4

Item No. 14696

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$49

Add

5 mg

$178

Add

10 mg

$306

Add

25 mg

$587

Add

AD57 (hydrochloride)

A polypharmacological cancer therapeutic

CAS No. 2320261-72-9

Item No. 13975

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$69

Add

5 mg

$297

Add

10 mg

$525

Add

ENMD-2076

A multi-kinase inhibitor

CAS No. 1453868-32-0

Item No. 22956

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$55

Add

5 mg

$215

Add

10 mg

$402

Add

GSK3179106

A RET kinase inhibitor

CAS No. 1627856-64-7

Item No. 24023

Formulation: A crystalline solid

Purity: ≥98%

RET Kinase Inhibitor 1

1 mg

$36

Add

5 mg

$153

Add

10 mg

$268

Add

25 mg

$587

Add

RAF265

A B-Raf and VEGFR2 inhibitor

CAS No. 927880-90-8

Item No. 16991

Formulation: A crystalline solid

Purity: ≥98%

CHIR265

1 mg

$43

Add

5 mg

$183

Add

10 mg

$258

Add

25 mg

$483

Add

AMG 706

A multikinase inhibitor

CAS No. 857876-30-3

Item No. 17671

Formulation: A crystalline solid

Purity: ≥98%

Motesanib

1 mg

$49

Add

5 mg

$143

Add

10 mg

$233

Add

50 mg

$726

Add

Fruquintinib

An inhibitor of VEGF1, -2, and -3

CAS No. 1194506-26-7

Item No. 29425

Formulation: A solid

Purity: ≥98%

HMPL-013

10 mg

$55

Add

50 mg

$242

Add

100 mg

$428

Add

250 mg

$934

Add

RPI-1

A RET kinase inhibitor

CAS No. 269730-03-2

Item No. 20384

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$36

Add

5 mg

$120

Add

10 mg

$219

Add

25 mg

$502

Add

LOXO-292

A RET kinase inhibitor

CAS No. 2152628-33-4

Item No. 33515

Formulation: A crystalline solid

Purity: ≥98%

ARRY-192
Selpercatinib

5 mg

$42

Add

10 mg

$72

Add

25 mg

$158

Add

50 mg

$251

Add

Pralsetinib

An inhibitor of RET

CAS No. 2097132-94-8

Item No. 33181

Formulation: A solid

Purity: ≥98%

BLU-667

1 mg

$53

Add

5 mg

$238

Add

10 mg

$423

Add

WHI-P180

A multi-kinase inhibitor

CAS No. 211555-08-7

Item No. 23452

Formulation: A crystalline solid

Purity: ≥98%

Janex 3

500 µg

$103

Add

1 mg

$194

Add

5 mg

$753

Add

Regorafenib-¹³C-d₃

An internal standard for the quantification of regorafenib

CAS No. 2126178-55-8

Item No. 25486

Formulation: A solid

Purity: ≥99% deuterated forms (d₁-d₃)

500 µg

$267

Add

1 mg

$505

Add

BAW 2881

A VEGFR inhibitor

CAS No. 861875-60-7

Item No. 18910

Formulation: A crystalline solid

Purity: ≥98%

NVP-BAW 2881

1 mg

$49

Add

5 mg

$223

Add

10 mg

$423

Add

25 mg

$933

Add

R 1530

A multi-kinase inhibitor

CAS No. 882531-87-5

Item No. 15255

Formulation: A crystalline solid

Purity: ≥98%

1 mg

$36

Add

5 mg

$110

Add

10 mg

$203

Add

25 mg

$462

Add

N-desmethyl Regorafenib N-oxide

An active metabolite of regorafenib

CAS No. 835621-12-0

Item No. 35102

Formulation: A solid

Purity: ≥90%

1 mg

$41

Add

5 mg

$128

Add

10 mg

$235

Add

25 mg

$534

Add

Regorafenib N-oxide

An active metabolite of regorafenib

CAS No. 835621-11-9

Item No. 35101

Formulation: A solid

Purity: ≥95%

1 mg

$36

Add

5 mg

$120

Add

10 mg

$219

Add

25 mg

$502

Add

ODM-203

A dual inhibitor of VEGFR and FGFR

CAS No. 1430723-35-5

Item No. 31451

Formulation: A crystalline solid

Purity: ≥98%

5 mg

$134

Add

10 mg

$240

Add

25 mg

$498

Add

50 mg

$795

Add

SPP 86

A RET inhibitor

CAS No. 1357349-91-7

Item No. 37390

Formulation: A solid

Purity: ≥98%

1 mg

$28

Add

5 mg

$125

Add

10 mg

$207

Add

25 mg

$413

Add

APS6-45

An inhibitor of RET^M918T and a derivative of sorafenib

CAS No. 2188236-41-9

Item No. 38417

Formulation: A solid

Purity: ≥98%

1 mg

$29

Add

5 mg

$113

Add

10 mg

$197

Add

25 mg

$247

Add

Displaying 1 - 25 of 29 Results

Cart Subtotal:$0

Product TypeClear Filters

Research AreaClear Filters

ApplicationClear Filters

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A solid

Purity: ≥99% deuterated forms (d1-d3)

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A solid

Purity: ≥90%

Formulation: A solid

Purity: ≥95%

Formulation: A crystalline solid

Purity: ≥98%

Formulation: A solid

Purity: ≥98%

Formulation: A solid

Purity: ≥98%

Purity: ≥99% deuterated forms (d₁-d₃)